4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055401
Chief Scientific Officer sold 11,100 shares at $51.79 ($574,869)
- Chief Scientific Officer acquired 11,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-16 | Option exercise | +11,100 | $6.32 | $70,152 | 11,779 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-16 | Sale | −11,100 | $51.79 | $574,869 | 679 | D: show line 2 in the form |
| Open-market sales · 11,100 sh · avg $51.79 · $574,869 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-10-16 | Option exercise · Stock Option (Right to Buy) | −11,100 | 267,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…